Intellia Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 14.21 M | $127.72 M | 19.20% | 12.89% |
| VANGUARD GROUP INC | 01/29/2026 | 13.01 M | $116.96 M | 17.79% | 11.81% |
| BLACKROCK, INC. | 02/12/2026 | 10.28 M | $92.39 M | 10.79% | 9.33% |
| STATE STREET CORP | 02/13/2026 | 6.42 M | $57.71 M | 29.13% | 5.83% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 5.33 M | $47.93 M | 139.23% | 4.84% |
| REGENERON PHARMACEUTICALS, INC. | 02/06/2026 | 3.70 M | $33.29 M | 0.00% | 3.36% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 2.70 M | $24.26 M | 10.17% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.70 M | $24.24 M | 4.15% | 2.45% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 2.35 M | $21.09 M | 8.45% | 2.13% |
| MORGAN STANLEY | 02/13/2026 | 2.33 M | $20.93 M | -61.35% | 2.11% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 2.19 M | $19.71 M | -6.90% | 1.99% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/11/2026 | 2.19 M | $19.69 M | -6.90% | 1.99% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.93 M | $17.37 M | 9.93% | 1.75% |
| FMR LLC | 02/17/2026 | 1.76 M | $15.82 M | -4.99% | 1.60% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 1.74 M | $15.62 M | 7.90% | 1.58% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.67 M | $15.04 M | 156.94% | 1.52% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 1.46 M | $13.09 M | -65.98% | 1.32% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.24 M | $11.17 M | 105.17% | 1.13% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 1.16 M | $10.39 M | 72.02% | 1.05% |
| JUPITER ASSET MANAGEMENT LTD | 02/10/2026 | 1.04 M | $9.33 M | -23.79% | 0.94% |
| CITADEL ADVISORS LLC | 02/17/2026 | 950.25 K | $8.54 M | 9,076.73% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 945.76 K | $8.50 M | 8.31% | 0.86% |
| STIFEL FINANCIAL CORP | 02/13/2026 | 931.39 K | $8.37 M | 19.64% | 0.85% |
| NORTHERN TRUST CORP | 02/17/2026 | 872.58 K | $7.84 M | -3.72% | 0.79% |
| UBS GROUP AG | 01/29/2026 | 859.55 K | $7.73 M | -22.44% | 0.78% |
| HRT FINANCIAL LP | 02/12/2026 | 764.89 K | $6.88 M | 100.00% | 0.69% |
| CITADEL ADVISORS LLC | 02/17/2026 | 754.60 K | $6.78 M | 101.17% | 0.68% |
| JPMORGAN CHASE & CO | 02/11/2026 | 743.70 K | $6.69 M | 68.80% | 0.67% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 02/12/2026 | 731.42 K | $6.58 M | 47.92% | 0.66% |
| CONTRARIUS GROUP HOLDINGS LTD | 02/11/2026 | 714.48 K | $6.42 M | -87.87% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 699.80 K | $6.29 M | 126.03% | 0.64% |
| MAREX GROUP PLC | 02/12/2026 | 623.60 K | $5.61 M | 0.16% | 0.57% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 608.67 K | $5.47 M | -31.64% | 0.55% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 591.28 K | $5.32 M | 1,076.65% | 0.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 579.90 K | $5.21 M | 29.82% | 0.53% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 02/17/2026 | 578.56 K | $5.20 M | 2.38% | 0.53% |
| BARCLAYS PLC | 02/13/2026 | 511.24 K | $4.60 M | 4.71% | 0.46% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2026 | 443.93 K | $3.99 M | 49.19% | 0.40% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 433.74 K | $3.90 M | -19.65% | 0.39% |
| INVESCO LTD. | 02/19/2026 | 433.29 K | $3.90 M | 5.83% | 0.39% |
| CITADEL ADVISORS LLC | 02/17/2026 | 433.10 K | $3.89 M | 136.02% | 0.39% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 401.66 K | $3.61 M | 26.73% | 0.36% |
| UBS GROUP AG | 01/29/2026 | 378.18 K | $3.40 M | -23.73% | 0.34% |
| FEDERATED HERMES, INC. | 02/12/2026 | 354.95 K | $3.19 M | 10,777.93% | 0.32% |
| JANE STREET GROUP, LLC | 02/12/2026 | 348.60 K | $3.13 M | 1,251.16% | 0.32% |
| PEAK6 LLC | 02/13/2026 | 346.70 K | $3.12 M | 0.81% | 0.31% |
| JANE STREET GROUP, LLC | 02/12/2026 | 332.47 K | $2.99 M | 66.15% | 0.30% |
| DIADEMA PARTNERS LP | 02/17/2026 | 316.90 K | $2.85 M | 100.00% | 0.29% |
| BIRCHVIEW CAPITAL, LP | 02/13/2026 | 315.40 K | $2.84 M | 425.67% | 0.29% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 315.00 K | $2.83 M | 36.96% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intellia Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 423 institutional investors and hedge funds held shares of Intellia Therapeutics Inc. The most heavily invested institutionals were:
ARK Investment Management LLC: 14.21 M
VANGUARD GROUP INC: 13.01 M
BlackRock, Inc.: 10.28 M
STATE STREET CORP: 6.42 M
D. E. Shaw & Co., Inc.: 5.33 M
REGENERON PHARMACEUTICALS, INC.: 3.7 M
94.54% of Intellia Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 121.79 M shares in the last 24 months. This purchase volume represents approximately $1.59 B in transactions.